35 Stocks Moving In Friday's Mid-Day Session

Gainers

• Biomerica, Inc. BMRA shares climbed 38.3% to $6.23. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.
• Progenity, Inc. PROG gained 23% to $1.87 after jumping over 40% on Thursday.
• Atea Pharmaceuticals, Inc. AVIR climbed 21.3% to $42.52 following data from Merck & Co's investigational oral antiviral molnupiravir, which boosted sentiment for Atea Pharmaceutical's AT-527, an oral antiviral drug candidate.
• Sono-Tek Corporation SOTK surged 14.4% to $4.69.
• Ramaco Resources, Inc. METC gained 14% to $14.03.
• Salem Media Group, Inc. SALM rose 13.7% to $4.22.
• Quotient Limited QTNT gained 13.2% to $2.65. Quotient reported commencement of review process of expanded immunohematology technical file dossier by European Notified Body.
• Bitfarms Ltd. BITF surged 13% to $4.8050 amid an increase in the price of Bitcoin and Ethereum.
• Silverback Therapeutics, Inc. SBTX gained 12.6% to $11.24.
• SunPower Corporation SPWR rose 11.9% to $25.36. SunPower will replace Cimarex Energy in the S&P MidCap 400 effective on Tuesday, October 5.
• Luby's, Inc. LUB gained 11.4% to $4.6550.
• Merck & Co., Inc. MRK jumped 9.4% to $82.17 after the company and Ridgeback announced investigational oral antiviral molnupiravir reduced risk of hospitalization or death by about 50% versus the placebo for patients with mild to moderate COVID-19 in Phase 3 interim analysis.
• Iterum Therapeutics plc ITRM gained 8.2% to $0.6040 after dropping over 8% on Thursday.
• QuickLogic Corporation QUIK rose 8.2% to $5.80. QuickLogic reported a strategic investment by current shareholders. The company said it expects Q3 revenue of $3.8 million to $3.9 million.
• Molecular Data Inc. MKD rose 8.4% to $0.3810. Molecular Data recently closed its $15 million registered direct offering.
• Aeterna Zentaris Inc. AEZS rose 8.9% to $0.8167 after climbing over 25% on Thursday.

Check out these big penny stock gainers and losers

Losers

• Omeros Corporation OMER fell 43.5% to $7.79 after the company announced the FDA notified it that they identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.
• Spire Global, Inc.. SPIR shares tumbled 43.3% to $7.11. Spire Global, Inc. recently appointed Dr. Kevin Petty as Vice President of Weather.
• Adagio Therapeutics, Inc. ADGI fell 35.8% to $27.12. Adagio Therapeutics recently announced new data from its COVID-19 antibody program.
• NeuroBo Pharmaceuticals, Inc. NRBO dropped 28% to $2.68 after the company announced a 4.3 million share offering at $3.25 per share.
• IronNet, Inc.. IRNT shares fell 22.7% to $13.18 after dropping 15% on Thursday.
• Vir Biotechnology, Inc. VIR dropped 21.9% to $33.98 in reaction to promising data from competitor Merck's COVID-19 antiviral candidate.
• Immunome, Inc. IMNM fell 17.6% to $20.06. Immunome will present preclinical data on anti IL-38 antibody program at The American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
• Benson Hill Inc. BHIL fell 17.3% to $5.89.
• Superior Drilling Products, Inc. SDPI shares fell 16.6% to $1.4601 after jumping 60% on Thursday.
• Guardant Health, Inc. GH dipped 16.6% to $104.24 following a Bloomberg report suggesting the company is exploring an acquisition of NeoGenomics.
• Clarus Therapeutics Holdings, Inc. CRXT dropped 16.3% to $4.4591. Clarus Therapeutics filed for offer and sale of up to 19.82 million shares of common stock by selling stockholders.
• Novavax, Inc. NVAX fell 16.2% to $173.56 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.
• Farmmi, Inc. FAMI fell 16.1% to $0.3881. Farmmi recently agreed to acquire all the shares of Jiangxi Xiangbo Agriculture and Forestry Development Co., Ltd (Xiangbo) for about RMB70 million.
• Lordstown Motors Corp. RIDE shares fell 15.1% to $6.78. Lordstown Motors issued production and financial update. Foxconn will purchase $50 million of Lordstown common stock at price of $6.8983 per share.
• CureVac N.V. CVAC dropped 15% to $46.40 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.
• Camber Energy, Inc. CEI shares fell 14.7% to $3.26 after gaining over 11% on Thursday.
• Moderna, Inc. MRNA dropped 12.3% to $337.31 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. Stephane Bancel, Chief Executive Officer at Moderna, made a large insider sell on September 30, according to a new SEC filing.
• Alzamend Neuro, Inc. ALZN fell 11.3% to $2.73. Ascendiant Capital analyst Edward Woo initiated coverage on Alzamend Neuro with a Buy rating and announced price target of $8.
• BioNTech SE BNTX declined 10.2% to $245.21 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. BioNTech dosed the first patient with its individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in Phase 2 clinical trial.